Biocon founder Kiran Mazumdar-Shaw has named her niece, Claire Mazumdar, as her successor. Claire Mazumdar, a successful CEO of Bicara Ther...

Novartis is significantly expanding its biomedical research and drug development operations in India, positioning it as a key global hub ou...

This may not have made it to the headlines, but for the last few months a tussle has been going on between health insurance companies and h...

Four years ago, Covid brought hospital stocks to the limelight. Since then, corporate actions like mergers and takeovers have kept them in ...

Prevention is key, and it's essential to address risk factors before symptoms develop when it comes to cardiovascular diseases, which is wh...

The new IT policy would focus on tier-2 and 3 cities, Narayan indicated, adding the government would strengthen educational institutions to...

Sharing details, Kamboj said the the Mumbai-based company is currently working on developing various products, including two major ones to ...

The meeting offers researchers an opportunity to closely interact with Nobel laureates from their discipline over seven days.

The Nasdaq-listed company will work with the government to expand affordable healthcare for infectious diseases such as HIV and tuberculosi...

The Nasdaq-listed company will work with the government to expand affordable healthcare for infectious diseases like HIV and tuberculosis, ...

The ministry defined the category of stem cells and their derivatives that would be termed a drug, and would thereby have to follow the pro...

The bench said it will hear the matter, but Noothi's lawyer Rahul Totala moved a separate plea to tag his matter with another case pending ...

The Environment Pollution Control Authority (EPCA) has suggested that a green tax of 30% be imposed on diesel vehicles to check their numbe...

Rather than killing cancer cells directly with chemo , the latest treatments are designed to promote the body's natural immune control over...

A new book by Amrita Chowdhury, country head of Mills and Boon subsidiary Harlequin India, is a blend of cyber crime, medical ethics and IP...

Affordable innovation is the only way forward, and India has a unique opportunity to deliver it to global markets by building excellence ac...

US-based biotech company Biogen Idec, is looking for partnerships across the pharma value chain, including in-licensing of new experimental...